Edition 3: How Insurance is Catching Up to the Future
Digital therapeutics (DTx) are rapidly transforming healthcare, bringing treatments to patients’ devices and making mental health and chronic care more accessible. But until recently, insurance lagged behind in recognizing DTx’s potential. Now, we’re seeing a pivotal shift as major insurers begin to cover digital therapeutics for a range of conditions. Here’s why it matters and what it could mean for patients, providers, and employers alike.
What’s Changing:
Insurance giants and government programs are stepping up, with recent FDA approvals and pilot insurance programs expanding DTx coverage. Why is this so impactful? Covering DTx means more people get access to essential care—right on their devices.
What’s Next:
As more insurers get on board, expect increased integration of DTx into employee benefit plans and provider options. This expansion not only benefits patients but gives providers and employers new tools to support mental health and chronic care.
VP Product Operations & Strategy, PlaySpace
Proposed Medicare Codes a Game-Changer for Digital Health
Tools that can actually help are amazing—but if they aren’t accessible, what's the point? The good news is, digital therapeutics are starting to make their way into insurance plans, and that’s a huge leap forward. Why? For starters, it means access to care is becoming easier and more affordable. But it also does something deeper—it brings these tools to the attention of more professionals, adding a personal touch that can really drive adoption. Oh, and let’s not forget: when these tools are covered, it’s a giant green light for entrepreneurs to dive into this space, knowing there's real investment behind it.
领英推荐
With more coverage, time, and innovation, we’re going to see a surge in new digital health solutions—and the impact will be massive. Products that didn’t even exist five years ago will become crucial to improving health outcomes. It’s an exciting time, and we’re only just scratching the surface!
Prescription Digital Therapeutics for Mental Health: A New Era in Psychiatry
Prescription digital therapeutics (PDTs) are revolutionizing mental health care, offering app-based treatments for conditions like anxiety, depression, and ADHD. FDA-approved examples include DaylightRx for anxiety and MamaLift Plus for postpartum depression, all designed to enhance traditional therapy.
However, concerns persist around patient data privacy, limited physician awareness, and access barriers like broadband and device availability. Though PDTs offer promising, accessible options, adoption is slowed by skepticism about effectiveness and variable insurance coverage. While some clinicians see potential, broader integration may hinge on stronger evidence and data protections.
And finally with this newsletter coming out on Halloween I wanted to shout out some of the competition we are holding at PlaySpace, here is one of our submissions for the best Halloween costume: